The startup pharmaceutical company is racking up expenses — without revenue to offset them — as it seeks to get its first product to market.Cingulate gets delisting warning as it presses to get first product to market
The startup pharmaceutical company is racking up expenses — without revenue to offset them — as it seeks to get its first product to market.